Sumatriptan Tablet
Product Images NDC 70518-1184

4 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 70518-1184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy Label

Remedy Label
Sumatriptan 100 mg oral tablet packaging label showing a quantity of 9 tablets. The label includes the product name, dosage strength, form, and repackager RemedyRepack Inc. The original manufacturer is Aurobindo, India. Additional details include an NDC number, barcode, QR code, and storage instructions.*
FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)
A line graph depicting estimated probability of response over time in minutes from initial dose, comparing placebo and Sumatriptan dosages of 25 mg, 50 mg, and 100 mg. The x-axis shows time up to 240 minutes and the y-axis shows probability percentage from 0% to 100%. Four distinct lines represent the response curves for placebo and each dosage group.*
FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)
A line graph depicting the estimated probability of remission or rescue over 24 hours from the initial dose for Sumatriptan tablets at doses 25 mg, 50 mg, and 100 mg compared to placebo. The x-axis shows time in hours and the y-axis shows the probability percentage.*
FDA Label Image

Sumatriptan Str

Sumatriptan Str
Chemical structure of Sumatriptan Succinate, showing the molecular arrangement with sulfonamide, indole, and succinate components as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.